In-111 ibritumomab scintigraphy (planar and SPECT) and FDG PET/CT before Y-90 ibritumomab treatment in a patient with mantle cell lymphoma

  1. Jiménez-Bonilla, J.F.
  2. Quirce, R.
  3. Banzo, I.
  4. Martínez-Rodríguez, I.
  5. Sainz-Esteban, A.
  6. Barragán, J.E.
  7. López-Cordovilla, J.J.
  8. Carril, J.M.
Journal:
Clinical Nuclear Medicine

ISSN: 0363-9762

Year of publication: 2007

Volume: 32

Issue: 12

Pages: 952-953

Type: Article

DOI: 10.1097/RLU.0B013E31815976A5 GOOGLE SCHOLAR

Sustainable development goals